Hansen Medical(R) to Showcase Magellan(TM) Robotic System at Global Embolization Symposium and Technologies (GEST) Scientific Meeting
MOUNTAIN VIEW, CA--(Marketwired - Jun 18, 2015) - Hansen Medical®, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced it will exhibit its Magellan™ Robotic System at the Global Embolization Symposium and Technologies (GEST) Scientific Meeting June 24 - June 27 at the FIBES II - New Conference Centre in Seville, Spain. The Company will showcase the Magellan 6Fr Robotic Catheter being used by Interventional Radiologists in embolization procedures, and will conduct Magellan Robotic System demonstrations at exhibit booth #5.
During this year's GEST meeting, the Magellan Robotic System will be featured in a scientific session entitled "Cutting Edge Technology" and in a company sponsored symposium.
The following session during GEST will include discussion about intravascular robotics:
June 26, Parallel session: Cutting edge technology, 2:15-3:45pm, Main Auditorium
- Robotic-assisted embolisation - Marc Sapoval, MD, PhD (Hopital Europeen Geoges-Pompidou)
Hansen Medical is also sponsoring an educational symposium on Wednesday, June 24 from 6:00 - 6:30 pm called "Clinical Update on Robotic Embolisation." Two speakers, Marc Sapoval, MD, PhD (Paris, France) and Mohamad Hamady, MD (London, UK), will discuss the role of robotic technology in providing enhanced precision, control and radiation protection in endovascular procedures. This session will take place in the FIBES II - New Conference Centre, Bruselas Lecture Room.
"The GEST meeting attracts medical experts from all over the world to discuss and debate the latest advances in embolization therapies," said Cary Vance, Hansen Medical's President and Chief Executive Officer. "We are excited that Magellan will be discussed as a cutting edge technology. Embolization procedures offer a minimally invasive approach in areas including Women's Health, Men's Health, and Cancer treatment. Magellan enables patients to benefit from robotic precision and control in these procedures, while helping to protect physicians from the harmful effects of exposure to ionizing radiation."